Position in INSM
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$1,712,423
-$695,408 QoQ
Shares Held
16,061
+9.1% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#298
of 666 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026OPPENHEIMER ASSET MANAGEMENT INC. holds $60,234,083 across 32 Biotechnology names. INSM ranks #8 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GMAB |
Genmab A/S
|
447,426 | $12,290,791 | |
| 2 | ONC |
BeOne Medicines Ltd.
|
35,781 | $10,196,511 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
17,931 | $8,906,863 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
19,608 | $5,902,596 | |
| 5 | TECH |
BIO-TECHNE Corp
|
39,080 | $2,760,999 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
29,098 | $2,277,499 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
8,356 | $2,013,545 | |
| 8 | INSM |
INSMED Inc
This page
|
16,061 | $1,712,423 |
All Filings in INSM
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,712,423 | 16,061 | Shares | Other | 2026-08-03 | |
| 2026-03-31 | $2,407,831 | 14,725 | Shares | Other | 2026-04-24 | |
| 2025-12-31 | $2,288,799 | 13,151 | Shares | Other | 2026-02-02 | |
| 2025-09-30 | $2,282,990 | 15,853 | Shares | Other | 2025-11-06 | |
| 2025-06-30 | $2,151,079 | 21,374 | Shares | Other | 2025-07-31 | |
| 2025-03-31 | $1,520,841 | 19,935 | Shares | Other | 2025-04-23 | |
| 2024-12-31 | $999,836 | 14,482 | Shares | Other | 2025-02-05 | |
| 2024-09-30 | $1,054,777 | 14,449 | Shares | Other | 2024-11-05 | |
| 2024-06-30 | $448,766 | 6,698 | Shares | Other | 2024-08-08 | |
| No filing history on record for this holder in this stock. | ||||||